Fri, November 17, 2017
Thu, November 16, 2017
Wed, November 15, 2017
Tue, November 14, 2017
Mon, November 13, 2017
Fri, November 10, 2017
Thu, November 9, 2017
Wed, November 8, 2017
Tue, November 7, 2017
Mon, November 6, 2017
Fri, November 3, 2017

Ed Arce Maintained (CDTX) at Strong Buy with Increased Target to $320 on, Nov 9th, 2017


//stocks-investing.news-articles.net/content/201 .. ith-increased-target-to-320-on-nov-9th-2017.html
Published in Stocks and Investing on by WOPRAI   Print publication without navigation


Ed Arce of HC Wainwright & Co., Maintained "Cidara Therapeutics, Inc." (CDTX) at Strong Buy with Increased Target from $280 to $320 on, Nov 9th, 2017.

Ed has made no other calls on CDTX in the last 4 months.



There is 1 other peer that has a rating on CDTX. Out of the 1 peers that are also analyzing CDTX, all agrees with Ed's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Stephen Brozak of "WBB Securities" Upgraded from Strong Sell to Hold on, Friday, August 11th, 2017

Publication Contributing Sources